You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 257 No. 23, June 19, 1987 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (35)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nicotine Replacement in Smoking Cessation

Absorption of Nicotine Vapor From Smoke-Free Cigarettes

Michael A. H. Russell, FRCP; Martin J. Jarvis, MPhil; Gay Sutherland, MPhil; Colin Feyerabend, PhD

JAMA. 1987;257(23):3262-3265.


Abstract

Nicotine replacement is a promising new approach to aid smoking cessation, and various methods of delivery are being developed. One new device is a smoke-free cigarette (Favor) that has been test-marketed in several US states. Without lighting up, it delivers nicotine vapor and is free of other harmful products of tobacco smoke. To examine its therapeutic potential, we measured plasma nicotine concentrations before, during, and after its use in eight male subjects. Very little nicotine was absorbed when it was puffed like a conventional cigarette. However, with an intensive schedule of puffing at four further smoke-free cigarettes over a 20-minute period, plasma nicotine concentrations were increased by an average of 17.3 ng/mL (107.3 nmol/L) (range, 10.9 to 30.4 ng/mL [67.6 to 188.5 nmol/L]). Heart rate and blood pressure also increased significantly. The rate of nicotine absorption was slow and resembled that obtained from nicotine chewing gum, suggesting that most of the nicotine was deposited in the mouth, throat, and large airways and did not reach the lung alveoli. Despite the slow absorption, the plasma nicotine levels produced could be of therapeutic value as an aid to smoking cessation.

(JAMA 1987;257:3262-3265)



Author Affiliations

From the Addiction Research Unit, Institute of Psychiatry (Dr Russell, Mr Jarvis, and Ms Sutherland), and the Poisons Unit, New Cross Hospital (Dr Feyerabend), London.


Footnotes

Reprint requests to Addiction Research Unit, Institute of Psychiatry, 101 Denmark Hill, London SE5 8AF, England (Dr Russell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Estimating the health consequences of replacing cigarettes with nicotine inhalers
Sumner
Tobacco Control 2003;12:124-132.
ABSTRACT | FULL TEXT  

A Double-blind Trial of a Nicotine Inhaler for Smoking Cessation
Tonnesen et al.
JAMA 1993;269:1268-1271.
ABSTRACT  

Controlled Trial of Nicotine Polacrilex Gum With Supportive Measures
Blondal
Arch Intern Med 1989;149:1818-1821.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.